FTC - Federal Trade Commission

01/12/2026 | Press release | Archived content

Edwards Lifesciences Corp. and JenaValve Technology, Inc., In the Matter of - The Federal Trade Commission issued an administrative complaint to block medical device supplier[...]

Last Updated
January 12, 2026
Case Status
Pending
In the Matter of EDWARDS LIFESCIENCES CORPORATION and JENAVALVE TECHNOLOGY, INC.
Docket Number
9442
Enforcement Type
Part 3 Administrative Complaints

Case Summary

The Federal Trade Commission issued an administrative complaint to block medical device supplier Edwards Lifesciences Corp.'s (Edwards) proposed acquisition of JenaValve Technology, Inc. (JenaValve) due to concerns that the acquisition would limit patient access to lifesaving medical devices used to treat a potentially fatal heart condition. On January 9, 2026, after a six-day trial, the U.S. District Court for the District of Columbia granted the FTC's request for a preliminary injunction to temporarily prevent Edwards from acquiring JenaValve.

Case Timeline

September 30, 2025
File
September 24, 2025
September 19, 2025
September 18, 2025
September 17, 2025
September 16, 2025
September 8, 2025
File
Joint Status Report (766.33 KB)
September 5, 2025
September 3, 2025
August 14, 2025
August 11, 2025
FTC - Federal Trade Commission published this content on January 12, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 16, 2026 at 21:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]